NDC 50458-575

Xarelto

Rivaroxaban

Xarelto is a Oral Granule, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is Rivaroxaban.

• Product ID: 50458-575_951fe5ba-5d57-43a6-98fa-3b227d7b4d1c
• NDC: 50458-575
• Product Type: Human Prescription Drug
• Proprietary Name: Xarelto
• Generic Name: Rivaroxaban
• Dosage Form: Granule, For Suspension
• Route of Administration: ORAL
• Marketing Start Date: 2021-12-01
• Marketing Category: NDA /
• Application Number: NDA215859
• Labeler Name: Janssen Pharmaceuticals, Inc.
• Substance Name: RIVAROXABAN
• Active Ingredient Strength: 155 mg/1
• Pharm Classes: Factor Xa Inhibitors [MoA],Factor Xa Inhibitor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 50458-575-01

1 BOTTLE in 1 CARTON (50458-575-01) > 1 GRANULE, FOR SUSPENSION in 1 BOTTLE

• Marketing Start Date: 2021-12-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Xarelto" or generic name "Rivaroxaban"

NDC	Brand Name	Generic Name
50090-3625	Xarelto	rivaroxaban
50090-3639	Xarelto	rivaroxaban
50090-4468	Xarelto	rivaroxaban
50090-4469	Xarelto	rivaroxaban
50458-575	Xarelto	rivaroxaban
50458-577	XARELTO	rivaroxaban
50458-578	Xarelto	rivaroxaban
50458-579	Xarelto	rivaroxaban
50458-580	Xarelto	Xarelto
50458-584	XARELTO	XARELTO
55154-1423	Xarelto	Xarelto
55154-1424	Xarelto	Xarelto
55154-1422	Xarelto	Xarelto